Uridine-5'-triphosphate (I) is converted to the tributylamine salt, which is then activated as the cyclic metaphosphate (II) employing DCC. Subsequent coupling of the cyclic phosphate (II) with 2'-deoxycytidine-5'-monophosphate (III) in the presence of Bu3N gives rise to the target tetraphosphate compound.